Dissolving microneedle patch-assisted transdermal delivery of methotrexate improve the therapeutic efficacy of rheumatoid arthritis

• Päätekijät: Weiman Zhao (Tekijä), Lijie Zheng (Tekijä), Jianhui Yang (Tekijä), Zihui Ma (Tekijä), Xinyi Tao (Tekijä), Qingqing Wang (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

AbstractMethotrexate (MTX) is a first-line treatment for rheumatoid arthritis (RA), but its clinical use is greatly limited by the adverse effects and poor patient compliance caused by traditional oral administration or injection. In recent years, some transdermal drug delivery systems have received...